IDH2 and glioblastoma: If the morphological features of glioblastoma are lacking, but this diagnosis is suspected, for instance, if histology would be consistent with an IDH-wildtype lower grade astrocytic glioma in an older patient, the WHO 2021 classification provides for a molecular diagnosis of glioblastoma.